import MCQGroup from '@/components/MCQGroup'
import { Callout } from 'nextra/components'

# Understanding Pancreatic Cancer

Pancreatic cancer refers to a group of malignant diseases affecting the pancreas, an organ with both endocrine and exocrine functions. This includes:

- Carcinoma of the head, body, and tail of the pancreas
- Neuroendocrine tumors

These types of cancer generally have a poor prognosis due to early metastasis, particularly of exocrine tumors, to adjacent organs such as the liver, peritoneum, and sometimes the lungs.

## Diagnosis

Pancreatic cancer has an incidence rate of 9 per 100,000 annually, mostly affecting individuals in their 70s and 80s, with no gender disparity. **Adenocarcinomas** account for 95% of cases, and 90% of these cases are infiltrating ductal adenocarcinomas. Neuroendocrine tumors make up another 3%. The five-year survival rate is less than 5%.

### Risk Factors and History

- **Lifestyle-related risks:** Smoking, obesity, excessive red meat consumption, diabetes, and alcohol.
- **Family history:**
  - Genetic predispositions, including BRCA1, BRCA2, familial adenomatous polyposis, Peutz-Jeghers syndrome, and Multiple Endocrine Neoplasia type 1.
  - Patients with increased risk should seek genetic counseling and clinical evaluation.
- **Medical history:**
  - Chronic pancreatitis increases risk by 5-15 times.
  - Hereditary pancreatitis raises the risk by 50-70 times.

### Symptoms

Symptoms often appear late and are non-specific, including:

- **Abdominal pain**: Often epigastric, sometimes radiating to the back.
- **Jaundice:** Usually due to carcinoma of the pancreatic head causing bile duct obstruction, 
  leading to dark urine, pale stools, and itching.
- **Anorexia and weight loss:** Common in cancer due to increased metabolism.
- **Ascites:** Caused by either physical pressure or invasion of the portal system.
- **Nausea and Vomiting**
- **General malaise**

Other symptoms related to specific conditions might include:

- **Paraneoplastic syndromes:** Such as thromboembolic disease.
- **Neuroendocrine tumors:**
  - *Insulinoma:* Confusion, hypoglycemia, and unconsciousness (90% benign).
  - *Gastrinoma:* Causes Zollinger-Ellison syndrome with severe peptic ulcers.
  - *Glucagonoma:* Characterized by necrolytic migratory erythema, hyperglucagonemia.
  - *Somatostatinoma:* Associated with diabetes, anemia, and postprandial fullness.

<details>
<summary>Additional Signs of Progression</summary>

- **Courvoisier’s sign:** Painless jaundice with a palpable gallbladder (less than 25% cases).
- **Virchow’s node:** An enlarged supraclavicular node, indicative of late-stage disease.

</details>

### Investigations

#### Blood Tests

- **Liver Function Tests (LFTs):** May show hyperbilirubinemia, elevated ALP, and GGT levels, indicating obstruction or liver involvement. ALT may indicate hepatocellular dysfunction.
- **Anemia** and **Thrombocytosis**: Possible findings.
- **CA19-9 tumormarker:** Useful for guiding treatment but limited as a diagnostic tool.

#### Imaging

- **Ultrasound:** Useful for detecting liver, bile duct, and pancreas anomalies but has limitations due to gas or bowel interference.
- **CT Scan:** Preferred for ongoing unexplained symptoms and staging new diagnoses.

#### Staging and Grading

- **Staging (TNM classification):**
  - **Tumor (T):** From TIS (in situ) to T4 (involving critical blood vessels).
  - **Node (N):** N0 (no lymph nodes) to N1 (regional nodes).
  - **Metastasis (M):** M0 (no distant spread) to M1 (distant spread).
  
- **Grading (G1 to G4):** G1 resembles normal cells, G4 is very aggressive.

A biopsy is essential for diagnosing pancreatic neuroendocrine tumors.

### Management

#### Prescriptive Strategies

- **Chemotherapy and Radiotherapy:** Are managed by specialists post-multidisciplinary team review.
- **Palliative Care:** Provided as necessary.

#### Non-Prescriptive Strategies

- **Referral:** Urgent two-week referrals to specialized centers for any suspicious cases.
- **Surgical Options:**
  - Only viable for 10-20% of patients due to advanced diagnosis stages.
  - **Whipple Procedure:** Pancreaticoduodenectomy with antrectomy, or modified with pylorus preservation.
  - **Distal Pancreatectomy:** For tumors in the body or tail.

- **Adjuvant Therapy:** Chemotherapy post-surgery enhances survival chances.
- **For Unresectable Tumors:** Biliary stenting or surgical bypass can alleviate symptoms like jaundice and itching.

<Callout emoji="⚠️">
**Warning:** Always monitor vital signs continuously during the procedure.
</Callout>

### References

- [Pancreatic Exocrine Tumors - Patient Info](https://patient.info/doctor/pancreatic-exocrine-tumours)
- [Pancreatic Endocrine Tumors - Patient Info](https://patient.info/doctor/pancreatic-endocrine-tumours)

---

<MCQGroup questions={[
  {
    question: "A 75-year-old man with a history of smoking presents with jaundice, weight loss, and dark urine. Imaging reveals a mass in the head of the pancreas causing bile duct obstruction. Which characteristic is most indicative of this being a pancreatic adenocarcinoma?",
    options: [
      "Slow progression and benign behavior",
      "Rapid metastasis to liver and peritoneum",
      "High incidence in individuals under 50",
      "Associated with hormonal hypersecretion"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! Pancreatic adenocarcinomas are known for their aggressive nature and tendency for early metastasis, particularly to the liver and peritoneum.",
    incorrectFeedback: "Pancreatic adenocarcinomas are aggressive and occur frequently in older adults, known for early metastasis, especially to the liver and peritoneal surfaces."
  },
  {
    question: "A 60-year-old woman, with a family history of Peutz-Jeghers syndrome, presents with abdominal pain and jaundice. Considering her medical background, how does her risk for pancreatic cancer compare to the general population?",
    options: [
      "Her risk is lower due to better genetic screening",
      "Her risk is similar to the average population",
      "Her risk is higher due to genetic predisposition",
      "Her risk is lower due to lifestyle adjustments"
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! Patients with genetic predispositions such as Peutz-Jeghers syndrome have a higher risk of developing pancreatic cancer.",
    incorrectFeedback: "Consider the role of genetic factors like Peutz-Jeghers syndrome, which significantly increases the risk of developing pancreatic cancer compared to the general population."
  },
  {
    question: "Which diagnostic marker is most commonly elevated in pancreatic cancer and is used primarily to guide treatment rather than initial diagnosis?",
    options: [
      "Alpha-fetoprotein (AFP)",
      "Carcinoembryonic antigen (CEA)",
      "CA19-9",
      "Prostate-specific antigen (PSA)"
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! CA19-9 is commonly elevated in pancreatic cancer and is primarily useful for treatment monitoring rather than initial diagnosis due to low specificity.",
    incorrectFeedback: "Remember, the tumor marker CA19-9, although not highly specific for diagnosis, is frequently elevated in pancreatic cancer and aids in treatment monitoring."
  },
  {
    question: "A 58-year-old man is diagnosed with a non-resectable pancreatic neuroendocrine tumor. Which treatment strategy is most appropriate for symptom management in this patient?",
    options: [
      "Chemotherapy and radiotherapy combination",
      "Surgical resection to completely remove the tumor",
      "Somatostatin analogs to control symptoms",
      "Biliary stenting for bile duct obstruction"
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! Somatostatin analogs can be effective in managing symptoms caused by neuroendocrine tumors, particularly those involving hormonal hypersecretion.",
    incorrectFeedback: "For non-resectable pancreatic neuroendocrine tumors, focus on managing symptoms, where somatostatin analogs can play a crucial role in controlling hormone-related symptoms."
  }
]} />